Please provide your email address to receive an email when new articles are posted on . Endovascular therapy for stroke due to anterior circulation large-vessel occlusion resulted in modestly better ...
The factor XIa inhibitor asundexian, envisioned as a safer alternative to current oral anticoagulants, didn't cause excess bleeding when given with antiplatelets in a pair of large phase 2, ...
BARCELONA, Spain—Promising results from multiple phase II studies of oral factor XIa inhibitors presented here at the European Society of Cardiology Congress 2022 warrant moving on to phase III trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results